[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 33,057
Sort by:

Musculoskeletal Disorders Drugs-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Musculoskeletal Disorders Drugs by types and applications Cost and profit status of Musculoskeletal Disorders Drugs, and marketing status Market growth drivers and challenges The report segments the North America Musculoskeletal Disorders Drugs market as: North America Musculoskeletal Disorders Drugs Market ...

February 2018 155 pages

Musculoskeletal Disorders Drugs-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Musculoskeletal Disorders Drugs by types and applications Cost and profit status of Musculoskeletal Disorders Drugs, and marketing status Market growth drivers and challenges The report segments the South America Musculoskeletal Disorders Drugs market as: South America Musculoskeletal Disorders Drugs Market ...

February 2018 140 pages

Musculoskeletal Disorders Drugs-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... Musculoskeletal Disorders Drugs by types and applications Cost and profit status of Musculoskeletal Disorders Drugs, and marketing status Market growth drivers and challenges The report segments the United States Musculoskeletal Disorders Drugs market as: United States Musculoskeletal Disorders Drugs Market ...

February 2018 150 pages

Nanostructured Drug-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... Drug market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Nanostructured Drug market as: Asia Pacific Nanostructured Drug Market ...

February 2018 149 pages

Nanostructured Drug-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Nanostructured Drug market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the China Nanostructured Drug market as: China Nanostructured Drug Market ...

February 2018 159 pages

Nanostructured Drug-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Nanostructured Drug-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nanostructured Drug industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 137 pages

Nanostructured Drug-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Nanostructured Drug market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the Europe Nanostructured Drug market as: Europe Nanostructured Drug ...

February 2018 130 pages

Nanostructured Drug-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Nanostructured Drug-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Nanostructured Drug industry, standing on the readers’ perspective, delivering detailed market data in Global ...

February 2018 149 pages

Nanostructured Drug-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary Nanostructured Drug-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nanostructured Drug industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 160 pages

Nanostructured Drug-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... Nanostructured Drug market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the India Nanostructured Drug market as: India Nanostructured Drug Market ...

February 2018 150 pages

Nanostructured Drug-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the North America Nanostructured Drug market as: North America Nanostructured Drug Market ...

February 2018 148 pages

Nanostructured Drug-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the South America Nanostructured Drug market as: South America Nanostructured Drug Market ...

February 2018 149 pages

Nanostructured Drug-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... market Market status and development trend of Nanostructured Drug by types and applications Cost and profit status of Nanostructured Drug, and marketing status Market growth drivers and challenges The report segments the United States Nanostructured Drug market as: United States Nanostructured Drug Market ...

February 2018 133 pages

Pharmaceutical Continuous-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Pharmaceutical Continuous market as: Asia Pacific Pharmaceutical ...

February 2018 138 pages

Pharmaceutical Continuous-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Pharmaceutical Continuous market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the China Pharmaceutical Continuous market as: China ...

February 2018 131 pages

Pharmaceutical Continuous-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Pharmaceutical Continuous-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical Continuous industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 142 pages

Pharmaceutical Continuous-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Pharmaceutical Continuous market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the Europe Pharmaceutical Continuous market as: Europe ...

February 2018 153 pages

Pharmaceutical Continuous-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Pharmaceutical Continuous-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical Continuous industry, standing on the readers’ perspective, delivering detailed market data in Global ...

February 2018 139 pages

Pharmaceutical Continuous-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary Pharmaceutical Continuous-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical Continuous industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 154 pages

Pharmaceutical Continuous-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... Pharmaceutical Continuous market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the India Pharmaceutical Continuous market as: India ...

February 2018 143 pages

Pharmaceutical Continuous-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Continuous market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the North America Pharmaceutical Continuous market as: North America ...

February 2018 135 pages

Pharmaceutical Continuous-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Continuous market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the South America Pharmaceutical Continuous market as: South America ...

February 2018 160 pages

Pharmaceutical Continuous-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... Continuous market Market status and development trend of Pharmaceutical Continuous by types and applications Cost and profit status of Pharmaceutical Continuous, and marketing status Market growth drivers and challenges The report segments the United States Pharmaceutical Continuous market as: United States ...

February 2018 138 pages

Vaccines-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Vaccines market as: Asia Pacific Vaccines Market ...

February 2018 149 pages

Vaccines-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the China Vaccines market as: China Vaccines Market: Regional ...

February 2018 152 pages

Vaccines-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Vaccines-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...

February 2018 157 pages

Vaccines-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the Europe Vaccines market as: Europe Vaccines Market: Regional ...

February 2018 150 pages

Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Summary Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Vaccines industry, standing on the readers’ perspective, delivering detailed market data in Global ...

February 2018 137 pages

Vaccines-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary Vaccines-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...

February 2018 137 pages

Vaccines-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the India Vaccines market as: India Vaccines Market: Regional ...

February 2018 150 pages

Vaccines-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the North America Vaccines market as: North America Vaccines Market ...

February 2018 137 pages

Vaccines-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the South America Vaccines market as: South America Vaccines Market ...

February 2018 145 pages

Vaccines-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... Vaccines market Market status and development trend of Vaccines by types and applications Cost and profit status of Vaccines, and marketing status Market growth drivers and challenges The report segments the United States Vaccines market as: United States Vaccines Market ...

February 2018 159 pages

Visceral Pain - Pipeline Review, H1 2018

US$ 2,000.00

... . The Visceral Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Visceral Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2018 51 pages

Trigeminal Neuralgia - Pipeline Review, H1 2018

US$ 2,000.00

... . The Trigeminal Neuralgia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Trigeminal Neuralgia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2018 54 pages

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) development landscape Develop ...

February 2018 60 pages

Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) development landscape Develop and design ...

February 2018 113 pages

Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2018

US$ 2,000.00

... . The Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacillary Dysentery (Shigellosis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2018 43 pages

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H1 2018

US$ 3,500.00

... also reviews key players involved in C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) targeted therapeutics development with ...

February 2018 104 pages

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H1 2018

US$ 3,500.00

... Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 59 pages

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H1 2018

US$ 3,500.00

... Human Papillomavirus Protein E7 (E7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 120 pages

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) development landscape Develop ...

February 2018 40 pages

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H1 2018

US$ 3,500.00

... Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 51 pages

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H1 2018

US$ 3,500.00

... reviews Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 49 pages

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 55 pages

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 46 pages

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 79 pages

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) development landscape ...

February 2018 54 pages

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) development landscape Develop ...

February 2018 90 pages

Hypoparathyroidism: Drug Development Pipeline Study, H1 2018

US$ 895.00

... that impact the Hypoparathyroidism industry. Excerpts from- “Hypoparathyroidism- Drug Development Pipeline Study”: Hypoparathyroidism pipeline comprises of 6 drugs under development as of February 2018. Of these, 3 drugs are in Phase 1 and 1 drug is in phase 2. Further, 2 drugs remain in Pre ...

February 2018 32 pages

Filters

Search

Categories

23,521
914
8,559
40
23

Publishers

72
1
6
4
18
50
16
3
112
292
33
30
34
6,128
163
13
120
12
142
51
363
8
25
84
36
7
8
14
6
49
113
7
1
1,818
10
579
11
2,786
7
24
5,307
44
31
54
216
1,098
40
32
7
37
46
43
50
2,538
208
40
26
7
6
2
4
32
15
606
3,346
2,222
11
22
1
16
38
228
2
7
10
4
79
4
26
50
1
5
6
2
2
32
2
13
17
1
11
107
36
1
18
195
172
6
4
2
1
5
4
9
1
72
12
27
50
33
1
27
27
1
2
1
42
55
14
18
1
323
954
555
2
1
2
5
88
72
59
37
41
22
2
14
5
23
2
2

Regions

14
13
12
11
8
7
6
3
3
2
2
1
4
7
19
8
1,367
101
83
57
51
50
48
34
28
27
26
25
25
22
22
21
20
19
19
19
19
19
19
19
19
18
18
18
18
17
17
16
16
16
16
16
16
16
16
15
15
14
13
13
12
12
11
11
11
11
11
10
10
8
7
5
1,703
741
22
20
14
1,325
701
597
31
30
7
6
6
5
5
4
5
5
5
4
3
1
1
1
1
25
4
11
2
2
2
2
693
7
13
10
6
46
12
6
57
4
24,205

Price

Date

Pages

Offers

16
16
10
44
5
1
2